People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prellis Biologics, Inc | — | Biotech / Pharma | Series B | $47.3M | $277.2M | 2022 |
Sean O'Sullivan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sean O'Sullivan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Marks | 1 | 20 |
| Alex Morgan | 1 | 10 |
| Rohit Sharma | 1 | 10 |
| Arvind Gupta | 1 | 3 |
| Shaun Holt | 1 | 2 |
| Noelle Mullin | 1 | 1 |
| Melanie Matheu | 1 | 1 |
| Lei Meng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.